实用医学杂志 ›› 2021, Vol. 37 ›› Issue (21): 2699-2706.doi: 10.3969/j.issn.1006⁃5725.2021.21.001

• 基础研究 •    下一篇

GTP酶Rab25在结直肠癌化疗耐药中的作用研究

谢竹夫1,2 黄启友1,2 姚菲1,2 周川人1,2 黄晓颖1,2 王强1,2 吴清明1,3   

  1.  1 武汉科技大学医学院(武汉 430070);2 职业危害识别与控制湖北省重点实验室(武汉 430070); 3 武汉科技大学附属天佑医院(武汉 430061)

  • 出版日期:2021-11-10 发布日期:2021-11-10
  • 通讯作者: 吴清明 E⁃mail:wuhe9224@sina.com
  • 基金资助:
    国家自然科学基金面上项目(编号:81573239)

The role of GTPase Rab25 in chemotherapy resistance of colorectal cancer

XIE Zhufu*,HUANG Qiyou, YAO Fei,ZHOU Chuanren,HUANG Xiaoying,WANG Qiang,WU Qingming.   

  1. Colleage of Medicine,Wuhan Uni⁃ versity of Science and Technology,Wuhan 430070,China;*Hubei Province Key Laboratory of Occupational Hazard Identification and ControlWuhan 430070China

  • Online:2021-11-10 Published:2021-11-10
  • Contact: WU Qingming E⁃mail:wuhe9224@sina.com

摘要:

目的 研究 GTP Rab25 与结直肠癌化疗耐药的关系。方法 MTT 比色法检测细胞的耐药 性;全转录组测序技术筛选结直肠癌细胞耐药相关的 GTP Rab 家族基因;基于生物信息学分析 Rab25 患者预后以及多药耐药标志物的相关性;实时荧光定量 PCR 和免疫印记法检测细胞 Rab25 RNA 表达水 平和蛋白水平;流式细胞术检测耐药细胞过表达 Rab25 前后的周期及凋亡。结果 抗癌药物处理,耐药株细胞存活率显著高于亲本株(P < 0.01);Rab25、Rab32 Rab38 在耐药株里面显著低表达(P < 0.001); Rab25 高表达的结直肠癌患者总体生存期更长(HR = 0.4,P < 0.05),Rab25 与多药耐药标志物 ABCB1 ABCC1 ABCG2 表达均呈负相关(P < 0.01);与 HCT⁃8 相比,耐药株 Rab25 RNA 和蛋白水平显著降低, 耐药株转染 Rab25 质粒后 RNA 和蛋白水平表达显著增高(P < 0.001);上调 Rab25 增强耐药细胞对药物的 敏感性(P < 0.001);上调 Rab25 增强药物对耐药细胞 G0/G1 期的阻滞,促进药物对耐药细胞的致凋亡作用 P < 0.001)。结论 上调Rab25可显著降低结直肠癌耐药细胞株的化疗耐药性。

关键词:

结直肠癌, 化疗耐药, GTP 酶Rab25, 顺铂, 5?氟尿嘧啶

Abstract:

Objective To study the relationship between GTPase Rab25 and chemotherapy resistance in colorectal cancer. Methods MTT colorimetric method was used to detect the drug resistance of cells. Whole tran⁃ scriptome sequencing technology was used to screen the GTPase Rab family genes related to the drug resistance of colorectal cancer cells. Bioinformatics was used to analyze the correlation of Rab25 with patient prognosis and multi⁃ drug resistance biomarkers. RT⁃PCR and Western Blot were used to verify the RNA and protein expression level of Rab25 in cells. Flow cytometry was used to detect the cycle and apoptosis of drug⁃resistant cells before and after the overexpression of Rab25. Results The cell survival rate of drug⁃resistant strains was significantly higher than that of parental strains treated with anticancer drugs(P < 0.01). Rab25,Rab32,and Rab38 were significantly lower expressed in drug⁃resistant strains(P < 0.001). Colorectal cancer patients with high expression of Rab25 had a longer overall survival(HR = 0.4,P < 0.05)and Rab25 was negatively correlated with the expression of multidrug resis⁃ tance markers ABCB1,ABCC1 and ABCG2(P < 0.01). Compared with HCT⁃8,the RNA and protein level of the drug⁃resistant strain Rab25 was significantly reduced,and the RNA and protein level of the drug⁃resistant strain was significantly increased after transfection of the Rab25 plasmid(P < 0.001). Up ⁃ regulation of Rab25 enhanced the sensitivity of drug⁃resistant cells to drugs(P < 0.001). Up⁃regulation of Rab25 enhanced drug⁃resistant cell G0/G1 blockade,and promoted drug⁃induced apoptosis of drug⁃resistant cells Effect(P < 0.001). Conclusion Up⁃regulation of Rab25 can significantly reduce the chemotherapy resistance of colorectal cancer drug⁃resistant cell lines. 

Key words:

colorectal cancer, chemotherapy resistance, GTPase Rab25, cisplatin, 5?fluorouracil ,